Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
anticonvulsants
anticonvulsants, absorption
anticonvulsants, bioavailability
anticonvulsants, blood level determination of
anticonvulsants, brand name
anticonvulsants, compliance
anticonvulsants, effectiveness
anticonvulsants, generic
anticonvulsants, pharmacokinetics
anticonvulsants, selection of
anticonvulsants, teratogenicity of
anticonvulsants, untoward effects of
behavioral disorder
brand name drug
carbamazepine
carbamazepine, toxicity
chest pain
children
complications
contraindications
controversies in neurology
cost
cost effectiveness
diabetes insipidus
dilantin
dilantin, serum level
drug interactions
drug of choice
efficacy
enzyme, induction
erythema multiforme
ethics in neurology
flushing
generic drugs
hospital length of stay
hospitalization
iatrogenic neurologic disorders
lamotrigine
manic-depressive
medical-legal aspects of neurology
migraine
migraine, treatment of
movement disorder
movement disorder, treatment of
mylan
mysoline
neck pain
pain
pain, central
pain, management of chronic
paresthesias
personality disorder
phantom limb
phenobarbital
practice guidelines
pregnancy, neurologic complications in
quality of care
quality of life
rash
recurrent
review article
risk factors
safety
seizure
seizure, breakthrough
seizure, recurrent
seizure, treatment of
sodium valproate
sumatriptan
teratogenesis
teratogenic drugs
topiramate
trauma
treatment of neurologic disorder
trigeminal neuralgia
trigeminal neuralgia, treatment of
triptans
Showing articles 100 to 150 of 6670 << Previous Next >>

CSF and Plasma Biomarkers in Patients with Iatrogenic Cerebral Amyloid Angiopathy
Neurol 103:e209828, Pollaci,G.,et al, 2024

Neuroleptic Malignant Syndrome
NEJM 391:1130-1138, Wijdicks,E.F.M. & Ropper,A.H., 2024

A 32-Year-Old Man with Painless Bilateral Shoulder Girdle Weakness and Atrophy
Neurol 103:e209915, Gutti,N.B.,et al, 2024

An Unusual Etiology of Lumbosacral Plexopathy in a Patient with HIV
Neurol 103:e209930, Madduluri,B.,et al, 2024

Anticoagulation vs Antiplatelets Across Subgroups of Embolic Stroke of Undetermined Source
Neurol 103:e209949, Grannam,M.,et al, 2024

Lentiviral Gene Therapy for Cerebral adrenoleukodystrophy
NEJM 391:1302-1312,1358, Eichler,F.,et al, 2024

Middle Meningeal Artery Embolisation for Nonacute Subdural Hematoma
NEJM 391:1901-1912, Ni,J.L.W.,et al, 2024

Adjunctive Middle Meningeal Artery Embolization for Subdural Hematoma
NEJM 391:1890-1900, Davies,J.M.,et al, 2024

Chronic Immunotherapy for Myasthenia Gravis
www.UptoDate.Com, Bird,S.J., 2024

Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine, A Phase 4, Randomized, Placebo-Controlled Trial
JAMA Neurol 81:1140-1149, Tepper,S.J.,et al, 2024

Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation
JAMA Neurol 81:1150-1158, Maarse,M.,et al, 2024

How Patients Are Using AI
BMJ 387:q2393, Stokel-Walker,C., 2024

2024 Guide for the Primary Prevention of Stroke:A Guideline From the American Heart Association/American Stroke Association
Stroke 55:e344-e424, Bushnell,C.,et al, 2024

Tranexamic Acid Within 4.5 Hours of Intracerebral Hemorrhage With the CTA Spot Sign, Systematic Review and Individual Patient Meta-Analysis
Neurol 103:e210104, Yassi,N.,et al, 2024

Safety and Efficacy of Staged, Bilateral Focused Ultrasound Thalamotomy in Essential Tremor, An Open-Label Clinical Trial
JAMA Neurol 81:939-946, Kaplitt,M.G.,et al, 2024

Miyazaki Syndrome as a Complication of Shunt Drainage
Ann Neurol 96:1230-1231, vanLanen,R.H.G.J., et al, 2024

Clinicopathologic Conference, Cryptococcal Meningoencephalitis
NEJM 391:2361-2369, Case 40-2024, 2024

Effect of IV Thrombolysis With Alteplase in Patients with Vessel Occlusion in the WAKE-UP Trial
Neurol 104:e209871, Galinovic,I.,et al, 2024

Cauda Equina Syndrome in the Third Trimester
BMJ 395:e078711, Ugas,M.A. & Ashkan,K., 2023

Surgical Treatment of Atrioesophageal Fistula:A Systematic Review
Ann Thorac Surg 116:421-428, Amirkhosravi,F.,et al, 2023

Dual Antiplatelet Treatment up to 72 Hours After Ischemic Stroke
NEJM 389:2413-2424, 2478, Gao,Y.et al, 2023

Clinical Outcomes and Safety Comparison of Vertebroplasty, Balloon Kyphoplasty,and Vertebral Implant for Treatment of Vertebral Compression Fractures
AJNR 44:1345-1351, Li,T.,et al, 2023

Trial of Botulinum Toxin for Isolated or Essential Head Tremor
NEJM 389:1753-1765, Marques,A.,et al, 2023

Blook Transfusion and Brain Amyloidosis, Should We Be Worried?
JAMA 330:921-922, Greenberg,S.M., 2023

Impact of Seizures While Driving Prior to Diagnosis in People with Focal Epilepsy, Motor Vehicle Accidents and Time to Diagnosis
Neurol 101:e1370-e1375, Bases,B.,et al, 2023

Lecanemab, Looking Before We Leap
Neurol 101:661-665, Burke,J.F.,et al, 2023

MR Imaging Patterns and Prognosis in Powassan Virus Encephalitis
Neurologist doi.10.1097/NRI.0000000000000533, Finelli,P.F., 2023

Mortality and Causes of Death in Children with Cerebral Palsy with Scoliosis Treated with and without Surgery
Neurol 101:e1787-e1792, Ahonen,M.,et al, 2023

Improving Neurology Clinical Care with Natural Language Processing Tools
Neurol 101:1010-1018, Ge,W.,et al, 2023

Coagulation Factor Expression and Composition of Arterial Thrombi in Cancer-Associated Stroke
Stroke 54:2981-2989, Yoo,J.,et al, 2023

Consensus Practice Guidelines on Postdural Puncture Headache from a Multisociety, International Working Group
JAMA Network Open 6:e2325387, Uppal,V.,et al, 2023

CHANTER Syndrome
Neurol 101:e2338-e2339, Rizkallah,B. & Rubin,D.B., 2023

Severe Amyloid-Related Imaging Abnormalities After Anti-B-Amyloid Monoclonal Antibody Treatment
Neurol 101:1079-1080, Bonami,S.,et al, 2023

Large Language Models in Neurology Research and Future Practice
Neurol 101:1058-1067, Romano,M.F.,et al, 2023

Incidence and Outcome of Neurologic Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Patients with Melanoma
Neurol 101:e2472-e2482, Pepys,J.,et al, 2023

Brexpiprazole for the Treatment of Agitation and Aggression in Alzheimers Disease
JAMA Neurol 80:1272-1273, Ballard,C., 2023

Cannabis-Related Disorders and Toxic Effects
NEJM 389: 2267-2275, Gorelick,D.A., 2023

Use of GPT-4 to Diagnose Complex Clinical Cases
NEJM AI doi:10.1056/AIp2300031, Eriksen,A.V.,et al, 2023

Study Finds ChatGPT Provides Inaccurate Responses to Drug Questions-Press Release
Am Soc Health Sys Pharm, Dec 5, Grossman,S., 2023

Antiplatelet Therapy or Not for Asymptomatic/Incidental Lacunar Infarction
Stroke 54:1954-1959, Bilski.A.,et al, 2023

Risk of Parkinson Disease Among Service Members at Marine Corps Base Camp Lejeune
JAMA Neurol 80:673-681, Goldman,S.M.,et al, 2023

Endovascular Therapy Versus Medical Treatment for Symptomatic Intracranial Artery Stenosis
Stroke 54:e305-e306, Luo,J.,et al, 2023

Intracerebral Haemorrhage Caused by Iatrogenic Cerebral Amyloid Angiopathy in a Patient with a History of Neurosurgery 35 Years Earlier
Lancet 402:11, Fandler-Hofler,et al, 2023

Donanemab in Early Symptomatic Alzheimer Disease, The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
JAMA 330:512-517, 510, Sims,J.R.,et al, 2023

Perioperative Management of Anticoagulant and Antiplatelet Therapy
NEJM Evid doi:10.1056/EVIDna2200322, Douketis,J.D. & Spyropoulos,A.C., 2023

Perioperative Acute Ischemic Stroke in Patients with Atrial Fibrillation
Ann Neurol 94:321-329, Shu,L.et al, 2023

Neurologic Manifestations of Long COVID Differ Based on Acute COVID-19 Severity
Ann Neurol 94:146-159, Giraldo,G.S.P.,et al, 2023

National Trends of Cerebral Venous Sinus Stenting for the Treatment of Idiopathic Intracranial Hypertension
Neurol 101:402-406, Khunte,M.,et al, 2023

Opioid-Associated Amnestic Syndrome Progressing to Diffuse Leukoencephalopathy
Neurohospitalist 13:109-110, Meng,D., & Randhawa,J., 2023

Atogepant for the Preventive Treatment of Chronic Migraine (PROGRESS): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial
Lancet 402:775-785, Pozo-Rosich,P.,et al, 2023



Showing articles 100 to 150 of 6670 << Previous Next >>